Lui Ng

Dr. Lui Ng


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ACAriel Ka-Man Chow
Ariel Ka-Man Chow
LNLui Ng
Lui Ng
CLColin Siu-Chi Lam
Colin Siu-Chi Lam
SWSunny Kit-Man Wong
Sunny Kit-Man Wong
TWTimothy Ming-Hun Wan
Timothy Ming-Hun Wan
RPRoberta Wen-Chi Pang
Roberta Wen-Chi Pang
Acquired resistance towards sorafenib treatment was found in HCC patients, which results in poor prognosis. To investigate the enhanced metastatic potential of sorafenib resistance cells, sorafenib-resistant (SorR) cell lines were established by long-term exposure of the HCC cells to the maximum tolerated dose of sorafenib. Cell proliferation assay and qPCR of ABC transporter genes (ABCC1-3) were first performed to confirm the resistance of cells. Migration and invasion assays, and immunoblotting analysis on the expression of epithelial to mesenchymal transition (EMT) regulatory proteins were performed to study the metastatic potential of SorR cells. The expression of CD44 and CD133 were studied by flow cytometry and the gene expressions of pluripotency factors were studied by qPCR to demonstrate the enrichment of cancer stem cells (CSCs) in SorR cells. Control (CTL) and SorR cells were also injected orthotopically to the livers of NOD-SCID mice to investigate the development of lung metastasis. Increased expressions of ABCC1-3 were found in SorR cells. Enhanced migratory and invasive abilities of SorR cells were observed. The changes in expression of EMT regulatory proteins demonstrated an activation of the EMT process in SorR cells. Enriched proportion of CD44+ and CD44+CD133+ cells were also observed in SorR cells. All (8/8) mice injected with SorR cells demonstrated lung metastasis whereas only 1/8 mouse injected with CTL cells showed lung metastasis. HCC cells with sorafenib resistance demonstrated a higher metastatic potential, which may be due to the activated EMT process. Enriched CSCs were also demonstrated in the sorafenib resistant cells. This study suggests that advanced HCC patients with acquired sorafenib resistance may have enhanced tumor growth or distant metastasis, which raises the concern of long-term sorafenib treatment in advanced HCC patients who have developed resistance of sorafenib.

6 March 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WYWing Lung Yau
Wing Lung Yau
CLColin Siu Chi Lam
Colin Siu Chi Lam
LNLui Ng
Lui Ng
ACAriel Ka Man Chow
Ariel Ka Man Chow
SCSylvia Tsz Ching Chan
Sylvia Tsz Ching Chan
RPRoberta Wen Chi Pang
Roberta Wen Chi Pang
Hepatocellular carcinoma (HCC) is one the the most fatal cancers worldwide. The poor prognosis of HCC is mainly due to the developement of distance metastasis. To investigate the mechanism of metastasis in HCC, an orthotopic HCC metastasis animal model was established. Two sets of primary liver tumor cell lines and corresponding lung metastasis cell lines were generated. In vitro functional analysis demonstrated that the metastatic cell line had higher invasion and migration ability when compared with the primary liver tumor cell line. These cell lines were subjected to microRNA (miRNAs) microarray analysis to identify differentially expressed miRNAs which were associated with the developement of metastasis in vivo. Fifteen human miRNAs, including miR-106b, were differentially expressed in 2 metastatic cell lines compared with the primary tumor cell lines. The clinical significance of miR-106b in 99 HCC clinical samples was studied. The results demonstrated that miR-106b was over-expressed in HCC tumor tissue compared with adjacent non-tumor tissue (p = 0.0005), and overexpression of miR-106b was signficantly correlated with higher tumor grade (p = 0.018). Further functional studies demonstrated that miR-106b could promote cell migration and stress fiber formation by over-expressing RhoGTPases, RhoA and RhoC. In vivo functional studies also showed that over-expression of miR-106b promoted HCC metastasis. These effects were related to the activation of the epithelial-mesenchymal transition (EMT) process. Our results suggested that miR-106b expression contributed to HCC metastasis by activating the EMT process promoting cell migration in vitro and metastasis in vivo.

28 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CLColin Siu-Chi Lam
Colin Siu-Chi Lam
ACAlvin Ho-Kwan Cheung
Alvin Ho-Kwan Cheung
SWSunny Kit-Man Wong
Sunny Kit-Man Wong
TWTimothy Ming-Hun Wan
Timothy Ming-Hun Wan
LNLui Ng
Lui Ng
WLWai Lun Law
Wai Lun Law
CD26, dipeptidyl peptidase IV, was discovered firstly as a membrane-associated peptidase on the surface of leukocyte. We previously demonstrated that a subpopulation of CD26+ cells were associated with the development of distant metastasis, enhanced invasiveness and chemoresistance in colorectal cancer (CRC). In order to understand the clinical impact of CD26, the expression was investigated in CRC patient's specimens. This study investigated the prognostic significance of tumour CD26 expression in patients with CRC. Examination of CD26+ cells has significant clinical impact for the prediction of distant metastasis development in colorectal cancer, and could be used as a selection criterion for further therapy. Tumour CD26 expression levels were studied by immunohistochemistry using Formalin-fixed paraffin embedded (FFPE) tissues in 143 patients with CRC. Tumour CD26 expression levels were correlated with clinicopathological features of the CRC patients. The prognostic significance of tumour tissue CD26 expression levels was assessed by univariate and multivariate analyses. CD26 expression levels in CRC patients with distant metastasis were significantly higher than those in non-metastatic. High expression levels of CD26 were significantly associated with advanced tumour staging. Patients with a high CD26 expression level had significantly worse overall survival than those with a lower level (p<0.001). The expression of CD26 was positively associated with clinicopathological correlation such as TNM staging, degree of differentiation and development of metastasis. A high CD26 expression level is a predictor of poor outcome after resection of CRC. CD26 may be a useful prognostic marker in patients with CRC.

Verified
Journal Article
Open access
PDF file
LNLui Ng
Lui Ng
SWSunny Kit-Man Wong
Sunny Kit-Man Wong
ZHZheng Huang
Zheng Huang
CLColin Siu-Chi Lam
Colin Siu-Chi Lam
ACAriel Ka-Man Chow
Ariel Ka-Man Chow
WLWai-Lun Law
Wai-Lun Law
CD26 has been reported as a marker for colorectal cancer stem cells endowed with tumor-initiating properties and capable of colorectal cancer (CRC) metastasis. In this study, we investigated the functional effect of CD26 on CRC angiogenesis and metastasis, and the potential underlying mechanism. The functional effects of CD26 overexpression or repression were determined by a wound healing experiment, and cell migration and invasion assays in vitro and in mouse models. Differentially expressed genes regulated by CD26 were identified by genome-wide mRNA expression array and validated by quantitative PCR. CD26 functionally regulated CRC cell migration and invasion in vitro and angiogenesis and metastasis in vivo. Genome-wide mRNA expression array and qPCR showed that MMP1 was up-regulated in CD26+ subpopulation, and a subsequent experiment demonstrated the regulatory effect of CD26 on MMP1 in CRC cell lines with CD26 repression or overexpression. Furthermore, overexpression of CAV1 abrogated the CD26-regulated MMP1 induction in CRC cell lines. This study demonstrated the functional roles of CD26 in inducing CRC migration, invasion, angiogenesis and metastasis and identified the potential involvement of MMP1 and CAV1 in such process. CD26 is an attractive therapeutic target for combating tumor progression to improve the prognosis of CRC patients.

14 March 2017 in Oncotarget
Verified
Journal Article
Open access
LNLui Ng
Lui Ng
TWTimothy Ming-Hun Wan
Timothy Ming-Hun Wan
JMJohnny Hon-Wai Man
Johnny Hon-Wai Man
ACAriel Ka-Man Chow
Ariel Ka-Man Chow
DIDeepak Narayanan Iyer
Deepak Narayanan Iyer
WLWai-Lun Law
Wai-Lun Law
Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer

17 July 2021 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
KLKristy T. K. Lau
Kristy T. K. Lau
LNLui Ng
Lui Ng
JWJason W. H. Wong
Jason W. H. Wong
HLHerbert H. F. Loong
Herbert H. F. Loong
WCWing Lok Chan
Wing Lok Chan
CWCarlos K H Wong
Carlos K H Wong